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Clematis is a botanical source for various pharmaceutically active components, which has long been used in conventional medi-
cine since the beginning of Chinese civilization. Increasing interest in Clematis medicinal resources has led to additional discov-
eries of triterpenoid saponins, flavonoids, coumarins, alkaloids and many other compounds in various Clematis species, and to 
investigations on their chemotaxonomy, molecular phylogeny and pharmacology. In continuation with our studies on Clematis 
chemistry and biology, we review the chemistry, chemotaxonomy, molecular biology and phylogeny of Clematis and their rele-
vance to drug efficacy and drug development. Various databases and technology have been used in literature search in order to 
characterize the global scientific effort. It is essential to study more species for both the sustainable utilization of Clematis medic-
inal resources and finding novel compounds with potential clinical utility. Systems biology and omics technologies will play an 
increasingly important role in future medicinal research involving bioactive compounds of Clematis. 
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Clematis is a genus of about 355 species [1] within the eu-
dicot family Ranunculaceae. The genus consists of typically 
vigorous, woody, climbing vines/lianas, which are mainly 
distributed in the temperate zone of the north of Earth’s 
equator. Clematis is a botanical source of various pharma-
ceutically active components, which has long been used in 
conventional medicine since the beginning of Chinese civi-
lization. Roots, rhizomes and stems of some Clematis spe-
cies are used to disperse wind-damp, unclog channels and 
ease pain. Wei Ling Xian and Chuan Mu Tong, recorded in 
the Chinese Pharmacopoeia (http://www.chp.org.cn/cms/ 
home/), are the most well-known Chinese herbal medicines 
obtained from Clematis species. The former is from Clema-
tis chinensis, C. hexapetala and C. mandshurica, while the 
latter from C. armandii and C. montana. Traditionally, 
Clematis medicine is administered orally to treat sexually 
transmitted infection, podagra, rheumatoid arthritis, bone 
disorder, chronic skin diseases, and is used as a diuretic. In 
folk medicine, Clematis is applied to body surfaces for blis-
ters and is also used as a cataplasm to treat purulent infec-
tions and ulcers. Different Clematis species may have dis-
similar drug effects. Though, it is pretty hard to authenticate 
Clematis species only by morphology. 
To date, at least 30 Clematis species have been charac-
terized for their chemical components. However, it is essen-
tial to study more species for both the sustainable utilization 
of Clematis medicinal resources and finding novel com-
pounds with potential clinical utility. In this brief review, 
we focus on recent progress in phytochemistry and chemo-
taxonomy of Clematis, as well as molecular taxonomy and 
pharmacology. 
1  Methods 
Information was withdrawn from Google Scholar and the 
journal databases Scopus, PubMed and CNKI (http:// 
www.cnki.net). 
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2  Chemical components of the genus Clematis 
2.1  Triterpenoid saponins 
Triterpenes are assembled in a four or five ring configura-
tion of 30 carbons with a number of oxygens appended. The 
aglycone of Clematis plants is of five-ring triterpenoid 
oleanane type, including oleanolic type (Figure 1A), olean- 
3β, 28-diol type (B), hederagenin type (C) and hederagenin- 
11,13-dien type (D). The conjugated glycosyl groups in-
clude glucose (Glc, D configuration), rhamnose (Rha, L 
configuration), galactose (Gal, D configuration), arabinose 
(Ara, L configuration), xylose (Xyl, D configuration) and 
ribose (Rib, D configuration). Since 2009, 19 novel triter- 
penoid saponins have been isolated from Clematis plants 
(Table 1). To date, more than 50 oleanolic type prototype  
saponins, more than 40 hederagenin type prototype saponins 
and two gypsogenin saponins have been found in Clematis 
plants [2,3]. Most of these saponins are bidesmosidic, i.e. 
C-3 and C-28 tie with the oligosaccharide chains. The 
monodesmosidic saponin is less common. Some oligosac-
charide chains are substituted with acetyl, caffeoyl (CA), 
isoferuloyl (IF), p-methoxy cinnamyl (MC) and 3,4-di- 
methoxy cinnamyl (DMC) groups (Figure 1). In addition, 
more than 20 secondary glycosides have been found [2], 
which lose their C-28 oligosaccharide chains after hydroly-
sis. 
Two new saponins from C. argentilucida showed note-
worthy cytotoxicity against human leukemia cells, hepato-
cellular carcinoma cells and glioblastoma cells [3]. Triter-
pene saponins from C. mandshurica inhibit human colon 
cancer cells [4]. Four triterpene glycosides from C. ganpin-
iana showed cytotoxicity against cancer cells and antibacte-
rial activity [5]. However, the full potential of the anticancer 




Figure 1  Aglycone and the substituent linked with glycosyl groups of triterpenoid saponins of Clematis. A, Oleanolic type; B, olean-3β, 28-diol type; C, 
hederagenin type; D, hederagenin-11,13-dien type; CA, caffeoyl; IF, isoferuloyl; MC, p-methoxy cinnamyl; DMC, 3,4-dimethoxy cinnamyl. Modified from 
[2]. 
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Table 1  Triterpenoid saponins found in Clematis medicinal plants in recent yearsa) 
 Compound Aglycone Oligosaccharide chain Species Tissue Reference 




D R1=Rib(1 3)→ -  
Rha(1 2)→ -Ara-, 
R2=H 
C. argentilucida root [3] 
2 3β-O-{β-D-ribopyranosyl-(1 3)→ - 
α-L-rhamnopyranosyl-(1 2)→ - 
[β-D-glucopyranosyl-(1 4)]→ -β-D- 
xylopyranosyl} oleanolic acid 
A R1=Rib(1 3)→ -Rha(1 2)→ - 
Glc(1 4)→ -Xyl-, 
R2=H, 
R3=H 
C. argentilucida root [3] 
3 3β-O-[β-D-xylopyranosyl-(1 3)→ - 
α-L-rhamnopyranosyl-(1 2)→ -[β-D- 
glucopyranosyl]-12-oleanene-3β, 28-diol 
B R= Xyl(1 3)→ -  
Rha(1 2)→ -Glc- 
C. argentilucida root [59] 
4 mandshunosides A C R1=Glc(1 4)→ - 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2=H, 
R3=H 
C. mandshurica roots, rhizomes [4] 
5 mandshunosides B A R1=Glc(1 4)→ - 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2=H, 
R3=H 
C. mandshurica roots, rhizomes [4] 
6 3-O-α-L-rhamnopyranosyl-(1 6)→ -β- 
D-glucopyranosyl-(1 4)→ -β-D- 
glucopyranosyl-(1 4)→ -β-D- 
ribopyranosyl-(1 3)→ -α-L- 
rhamnopyranosyl-(1 2)→ -α-L- 
arabinopyranosyl oleanolic acid 
28-O-β-D-glucopyranosyl-(1 6)→ -β-D- 
glucopyranoside (clematomandshurica  
saponin E) 
A R1=Rha(1 6)→ - 
Glc(1 4)→ -Glc(1 4)→ - 
Rib(1 3)→ -Rha(1 2)→ -Ara-, 
R2= Glc(1 6)→ -Glc-, 
R3=H 
C. mandshurica roots, rhizomes [60] 
7 clematochinenosides A C R1=Glc(1 2)→ -Rha(1 6)→ - 
Glc(1 3)→ -Glc(1 4→ )- 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-,  
R2= Rha(1 4)→ - 
Glc(1→6)-Glc- 
C. chinensis roots, rhizomes [8] 
8 clematochinenosides B C R1=Glc(1 2)→ -Rha(1 6)→ - 
Glc(1 3)→ -Glc(1 4)→ - 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ - 
Glc(1 6)→ -Glc- 
C. chinensis roots, rhizomes [8] 
9 clematochinenosides C C R1=Rha(1 6)→ -Glc(1 4)→ - 
Glc(1 3)→ -Glc(1 4)→ - 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ - 
Glc(1 6)→ -Glc- 
C. chinensis roots, rhizomes [8] 
10 clematochinenosides D C R1=Glc(1 4)→ -Glc(1 4)→ - 
Rib(1 3)→ -Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ -Glc(1 6)→ - 
Glc- 
C. chinensis roots, rhizomes [8] 
11 clematochinenosides E C R1=Glc(1 4)→ -Glc(1 4)→ - 
Rib(1 3)→ -Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ -Glc(1 6)→ - 
Glc- 
C. chinensis roots, rhizomes [8] 
    (To be continued on the next page)
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     (Continued) 
 Compound Aglycone Oligosaccharide chain Species Tissue Reference 
12 clematochinenosides F A R1=Glc(1 4)→ -Glc(1 4)→ - 
Rib(1 3)→ -Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ -Glc(1 6)→ - 
Glc-, R3=H 
C. chinensis roots, rhizomes [8] 
13 clematochinenosides G C R1=Glc(1 3)→ -Glc(1 4)→ - 
Glc(1 4)→ -Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ -Glc(1 6)→ - 
Glc- 





C. ganpiniana roots, rhizomes [5] 
15 hederagenin 3β-O-α-L-arabinopyranoside C R1=Ara, 
R2=R3=H 
C. ganpiniana roots, rhizomes [5] 
16 3β-O-α-L-rhamnopyranosyl-(1 2)→ - 
α-L-arabinopyranosyl oleanoic acid 
A R1=Rha(1 2)→ -Ara-, 
R2=H, 
R3=H 
C. ganpiniana roots, rhizomes [5] 
17 α-hederin C R1=H, 
R2=H, 
R3=H 
C. ganpiniana roots, rhizomes [5] 
18 3-O-β-[(O-α-L-rhamnopyranosyl- 
(1 6)→ -O-β-D-glucopyranosyl- 
(1 4)→ -O-β-D-glucopyranosyl- 
(1 4)→ -O-β-D-ribopyranosyl- 




(1  4)→ -O-β-D-glucopyranosyl- 
(1 6)→ -β-D-glucopyranosyl ester 
(clematichinenoside AR2) 
A R1=Rha(1 6)→ - 
Glc(1 4)→ -Glc(1 4)→ - 
Rib(1 3)→ -Rha(1 2)→ -Ara-, 
R2= Rha(1 4)→ -Glc(1 6)→ - 
Glc-, 
R3=OH 
C. chinensis roots [61] 
19 23-O-acetyl-hederagenin-3-O-β-D- 
ribopyranosyl-(1  3)→ - 
α-L-rhamnopyranosyl-(1  2)→ - 
α-l-arabinopyranoside 
(parvilobaside A) 
C R1=Rib(1 3)→ - 
Rha(1 2)→ -Ara-, 
R2= H, 
R3=Ac 
C. parviloba stem [62] 
a) Aglycone: A, oleanolic type; B, olean-3β, 28-diol type; C, hederagenin type; D, hederagenin-11,13-dien type. The locations of R1, R2 and R3 are 
shown in Figure 1. 
 
 
much more pharmacological studies are performed. 
Traditionally, Wei Ling Xian is used to treat gout, obsti-
nate bi-syndrome, rheumatism, limb numbness, cold pain in 
the lumbus and knees, and inhibited bending and stretching, 
etc. Correspondingly, the triterpene saponin AR-6 from C. 
chinensis, a source plant of Wei Ling Xian, has a potential 
anti-inflammatory effect in rats with collagen-induced ar-
thritis, which inhibits the expression of NF (nuclear factor) 
-κB p65 subunits, TNF (tumor necrosis factor) -α and COX 
(cyclo-oxygenase)-2 [6]. Anti-arthritis effects of AR-6 were 
related to substantial decline of nitric oxide and TNF-α 
generated by peritoneal macrophages [7]. In addition, AR-6 
appreciably reduced the propagation of synoviocyte. Multi-
ple triterpene saponins of C. chinensis showed the potential 
anti-inflammatory activity with inhibitory activities against 
COX-1 and COX-2 enzymes [8]. Saponins might be re-
sponsible for the inhibition effects of C. chinensis on the 
pro-inflammatory and degradative mediators associated 
with inflammatory arthritis [9]. The saponin fraction from 
this plant showed the therapeutic effect on monosodium 
iodoacetate induced osteoarthritis via sheltering articular 
cartilage [10]. The release of the full potential of Clematis 
saponins calls for more extensive and deeper investigations. 
2.2  Flavonoids and anthocyanins 
Flavonoids (or bioflavonoids) are a class of plant secondary 
metabolites. More than 50 flavonoid compounds have been 
isolated or detected from Clematis [2,11–14], the aglycones 
of which are mainly apigenin，kaempfeml，luteolin and 
quercetin. Sugar moieties are connected to the aglycone 
through either the oxygen or the carbon atom. Flavonoids of 
Clematis are categorized, according to chemical structure, 
into flavonols, flavones, flavanones, isoflavones and their 
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glycosides, xanthones and anthocyanidins. 
Flavonoids were the major vigorous compounds in four 
preparative extracts of C. terniflora, which might be re-
sponsible for reducing sensitivity to painful stimuli and an-
ti-inflammatory effect in rats with carrageenan-induced per-
sistent non-bacterial prostatitis [15]. Anti-inflammatory, 
pain-relieving and fever-reducing effects of the aqueous 
extract of C. brachiata leaf in male rats may be due in part 
to the flavonoids [16]. Two flavone C-glycosides from C. 
rehderiana showed potent antioxidant activities [12]. Stud-
ies of pharmacological effects of Clematis flavonoids are 
still in the burgeoning stage. 
Twenty-four lignans isolated from Clematis are mainly 
eupomatene lignans, cyclolignans, monoepoxylignans, bi-
sepoxylignans and lignanolides [2]. Six coumarin com-
pounds have been isolated [2,17]. Eleven alkaloids isolated 
from Clematis fall into two categories: aporphine and ter-
penoid alkaloid. Two aporphine alkaloids showed potent 
antifungal activities [18]. A mannose-binding lectin was 
separated from C. Montana and showed antiviral and apop-
tosis-inducing activities [19]. Many other compounds were 
also isolated from various Clematis species, such as phe-
nolic glycosides [20], volatile oils, triterpenes, steroids, or-
ganic acids and their derivatives [21], macrocyclic com-
pounds and others [22]. Their functions and pharmacologi-
cal effects await further studies. 
3  Chemotaxonomy of Clematis 
The genus Clematis was founded by Linnaeus (1753) with 
only nine species. The following taxonomic studies in-
creased the number of species: Johnson [23] and Grey- 
Wilson [24] independently summarized 314 and 297 species 
respectively; Wang and Li [1] depicted 355 species in the 
new classification of the genus, with around 150 species 
scattered in China. Four subgenera and ten sections are pos-
sibly defined based on a number of essential morphological 
characters of vegetative and floral organs. The four subgen-
era are (1) Cheiropsis Peterm.: section Cheiropsis DC.; (2) 
Clematis Keener & Dennis: sect. Clematis Tamura, Mecla-
tis Baill., Fruticella Tamura, Naraveliopsis Hand.-Mazz, 
Viticella DC. and Tubulosae Decne.; (3) Viorna Gray: sect. 
Viorna Prantl and Archiclemaits Tamura; and (4) Atragene 
Torr. & Gray: sect. Atragene DC. A consensus has not been 
reached on taxonomy, origin and systematic location of this 
genus. 
According to pharmacophylogeny, plants with close ge-
netic relationship are similar in systematic classification and 
chemical components [25,26]. A chemosystematic study of 
sect. Viorna, subsect. Viornae was performed using flavo-
noid distribution patterns [27]. The close relationship be-
tween C. viorna and C. reticulata inferred from their form 
and structure and geographical allocation was corroborated 
by the resemblance of their flavonoid profiles. The supposi-
tion that C. glaucophylla recently derived from C. versicol-
or was propped up by their alike flavanoid contours, and the 
flavonoid multiplicity of C. pitcheri samples parallelled 
their morphological diversity. Flavonoids were used as 
chemical markers to argue the taxonomy of Ranunculaceae 
[28]. Feng et al. [29] compared the total flavonoid content 
of above-ground parts of 11 Clematis species. C. apiifolia 
leaves had the highest (5.581%) total flavonoid while C. 
huchouensis had only 0.195%. The amount of flavones in 
different species varied much. The cluster analysis based on 
the flavonoid content set apart the species of the subgenus 
Clematis and those of the subgenus Viorna, except C. terni-
flora and C. huchouensis. The aerial parts of C. apiifolia 
and C. finetiana could be used for flavonoid drug develop-
ment.  
Plant saponins have been used as chemotaxonomic 
markers to differentiate various taxa [30–32]. Saponins have 
been separated from a range of Clematis species [2,11], 
some of which were used for the chemosystematic study. 
Muhammad Ishtiaq et al. [33] analyzed 15 populations, 
representing 12 species of sections Rectae, Clematis, 
Meclatis, Tubulosae and Viorna, with HPLC (High-   
performance liquid chromatography) linked with diode ar-
ray detector and ESI (electrospray ionization)-MS (mass 
spectrometry) [34]. A cluster tree was constructed in terms 
of the distribution of nine saponins and their peak area in 
the respective species. Three clades were identified. Clade I 
includes species of sect. Rectae of subgenus Clematis, C. 
finetiana, C. armandii, C. chinensis and C. terniflora, which 
share five saponins: Huzhangoside B (HGB), Clem- 
atichinenoside C (CCC), Seiboldianoside A (SDA), Hu-
zhangoside D (HGD) and Clematichinenoside B (CCB). 
Clade II has C. apiifolia, C. argentilucida, C. ganpiniana 
and C. peterae, which belong to sect. Clematis and share 
saponins CCB, HGD, CCC and HGB. C. henryi of subge-
nus Viorna shares HGD and Clemochinenoside A (CCA) 
with C. heracleifolia of subgenus clematis and they were 
grouped together in clade III. This illogicality implies that 
more saponins and/or other secondary metabolites should be 
used in the chemotaxonomic analysis. C. huchouensis of 
subgenus clematis was quite different in total flavonoid [29] 
and saponin composition, which may have divergent sec-
ondary metabolic pathway. 
Many studies have investigated the chemical components 
and bioactivities of Radix et Rhizoma Clematidis (Wei Ling 
Xian), Caulis Clematidis Armandii (Chuan Mu Tong) and 
other Clematis species. Triterpenoid saponins are rich in 
many species (Table 1) and give multiple pharmacological 
effects. However, raw drugs from other species are also 
found on the market without verification of efficacy, which 
may be abused clinically. It is therefore obligatory to re-
solve the distribution and the contents of the pharmaceutical 
ingredients in the approved Clematis species for standardi-
zation and quality control. Sun et al. [35] developed a 
straightforward and precise method with HPLC and evapo-
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rative light scattering detection to concurrently resolve five 
triterpenoid saponins of Clematis. The chemical outlines 
were used to identify the botanical origin of ten Clematis 
samples. The contents of HGD and 3-O-α-L-ara(2-1)-α- 
L-rha(4-1)-β-D-rib pulsatiloside C were much higher in C. 
chinensis than in other species, which match its efficacy in 
clinical use. However, these saponins were not found in the 
above-ground part of C. manshurica, suggesting that the 
aerial fraction of this plant is not suitable as a source of Wei 
Ling Xian. The saponins were abundant in C. ganpiniana 
and C. apiifolia var. obtusidentata, which are promising 
pharmaceutical resources. No triterpenoid saponins were 
spotted in C. armandii, which agrees with previous chemi-
cal studies [36]. Thus its drug effects might be associated 
with other compounds. Five saponins in the roots and stems 
of C. ganpiniana, C. apiifolia and C. apiifolia var. obtusi-
dentata were more abundant than those in the whole plants 
except for CCB and CCC of C. apiifolia, which suggests 
that root and stem might be a better medicinal part than the 
leaves. 
The research group led by Cheng YY and Xiao PG per-
formed a series of Clematis studies. A simple and fast gra-
dient HPLC-MS method was built up and validated for par-
allel determination of CCB, HGD, CCC and HGB in Radix 
Clematidis and related species [37]. Optimally, the saponins 
were well separated in 25 min. The samples hold a wide 
range (0.0652–41.7 mg/g) of the four analytes. Radix 
Clematidis of Tianmu mountain, Zhejiang, China has the 
highest saponin content (41.7 mg/g), which was about seven 
times that in the commercial Radix Clematidis (China mar-
ket) (5.80 mg/g). This could be caused by different harvest 
time and places, suggesting that the source of Radix Clema-
tidis should be defined and curbed. The advantages of this 
method are good linearity, high sensitivity, precision, accu-
racy and shorter time, which are obliging in the quality con-
trol of Clematis medicine. Triterpenoid saponins were spot-
ted by qualitative HPLC-MS/MS of root and rhizome of 18 
Clematis samples and the whole plant of C. puberula var. 
ganpiniana and C. terniflora [38]. The HPLC-MSn identi-
fied 17 oleanolic acid or hederagenin saponins, which were 
used for phylogenetic relationship inference. Three branch-
es were identified based on the 17 peaks. The first branch 
comprised C. lasiandra (subgenus Viorna), C. finetiana, C. 
terniflora (whole plant), C. grandidentata and the outgroup 
species R. sieboldii. The next branch contained C. chinensis 
and other seven species of subgenus Clematis. The third 
cluster consisted of C. chinensis and other five species of 
subgenus Clematis, which are closer to the second cluster 
than to the first one. The two C. chinensis samples did not 
bunch together, which might be due to different collection 
time and area. The similar reason is valid for two samples of 
C. uncinata. HGB could be unequivocally identified in all 
taxa. All 17 compounds were present in C. puberula var. 
ganpiniana, C. apiifolia and C. argentilucida. Further com-
prehensive study must incorporate more species to check 
the appropriateness of these molecules for chemotaxonomy 
of the whole genus. Flavonoids and lignans are important 
medicinal compounds, which should be further examined to 
see if they reveal any additional information about the rela-
tionships within Clematis. 
Proteins and enzymes are the center players of the physi-
ological metabolic pathways of plant cells. Proteins can be 
biomarkers for cataloging of botanical medicines. Two di-
mensional gel electrophoresis of leaf protein was useful for 
examination of the systematic relationship of section Clem-
atis [39]. Significant variety was found among the 1085 
spots scored: only 255 spots were shared by all. Nine pro-
teins were only present in C. chinensis and absent in C. 
finetiana and C. armandii, although they are closer to each 
other than to other taxa. C. apiifolia, C. peterae, C. argenti-
lucida and C. ganpiniana form a group. The genetic dis-
tance 0.4–0.45 and 0.25–0.55 was observed at intra-subsec- 
tion level in Clematis and Rectae respectively. Proteomics 
is a capable taxonomic tool and the differentially expressed 
proteins provide hints for deciphering the distinction     
in metabolic pathway of different species. In addition, Shi  
et al. [40] suggested that the macrocyclic glucosides from  
C. chinensis, C. armandii, C. hexapetala and C. mands-
hurica are useful for the chemotaxonomy of sect. Clematis. 
Even with these studies, the relationships among Clematis 
species have not been resolved. Molecular methods have  
to be combined with morphology and chemotaxonomy in 
the elucidation of the pharmacophylogeny of Clematis. 
4  Molecular taxonomy and molecular  
phylogeny 
RAPD (random amplification of polymorphic DNA) is a 
type of PCR reaction, and the DNA sections that are ampli-
fied are haphazard [41]. The random primers of 8–12 bp 
and the genomic DNA template are used in the PCR. By 
resolving the PCR product patterns, a semi-distinctive pro-
file can be garnered. Among 59 species and 24 varieties in 
six sections of three Clematis subgenera in Yunnan of 
Southwest China [42], 56 are endemic to China and 16 are 
only found in Yunnan. RAPD was used to study 12 Clema-
tis species of Yunnan [43]. Selected ten RAPD primers 
were used in the random amplification and 89 polymorphic 
DNA bands were generated. The 12 species can be unam-
biguously identified. More importantly, the cluster tree ba-
sically mirrored the systematic relationship of the involved 
species. The subgenus Cheiropsis, the most ancient group, 
are basal to other taxa. C. buchananiana, C. connata and C. 
ranunculoides of subgenus Viorna are basal to subgenus 
Clematis. Caulis clematidis armandii (Chuan Mu Tong) is a 
traditional Chinese herbal medicine. The botanical origins 
of Chuan Mu Tong are the dried stems of C. armandii and 
C. montana. Chuan Mu Tong has the effects of heat-clear- 
ing, dieresis, activating blood to dredge vessels, and thus is 
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used to treat edema, gonorrhea, dysuria, rheumatoid arthritis, 
amenorrhea and hypogalactia [44]. Due to the morphologi-
cal resemblance, it is hard to distinguish C. armandii and C. 
montana from other Clematis species. The following spe-
cies are also marketed in China as Chuan Mu Tong [44]: C. 
finetiana, C. kerriana, C. argentilucida, C. peterae, C. api-
ifolia var. obtusidentata, C. tangutica, C. meyeniana and C. 
uncinata of subgenus Clematis, C. leschenaultiana, C. 
lasiandra, C. henryi, C. chrysocoma, C. pogonandra and C. 
trullifera of subgenus Viorna, and C. macropetala of sub-
genus Atragene. The distribution area of these species is 
less extensive than that of C. montana and C. armandii, and 
some endangered species should be protected [45]. Moreo-
ver, although these species are similar to raw plants of 
Chuan Mu Tong in drug efficacy, they are sometimes used 
for specific purposes in some regions and their pharmaceu-
tical ingredients have not been investigated comprehen-
sively. Other plants (e.g. Aristolochia and Akebia) were also 
mistakenly used as Chuan Mu Tong, which may cause se-
rious toxicity [44]. Guo et al. [46] established a molecular 
method to discern Caulis clematidis armandii from its fre-
quent contaminants. The RAPD-based dendrogram illus-
trated that evolutionarily ancient C. montana is basal to 
other taxa and C. urophylla and C. lasiandra of subgenus 
Viorna are basal to the seven species of subgenus Clematis, 
which is not incongruent with RAPD results of Pu et al. [43]. 
C. armandii is closer to C. finetiana than to C. argentilucida, 
C. peterae var. trichocarpa and C. apiifolia, which well 
agrees with the chemotaxonomic results of Muhammad 
Ishtiaq et al. [33]. Since C. montana and C. armandii are 
only distantly related, it is crucial to carry out a detailed 
study to uncover the physical basis of their common drug 
efficacy. The sequences of two RAPD fragments specific 
for C. armandii and C. montana were determined and PCR 
primers were designed for sequence characterized amplified 
region (SCAR) markers [46]. The two SCAR markers were 
specific to both C. armandii and C. montana but were not 
present in other species, which can be used in quality con-
trol of Chuan Mu Tong. RAPD was also used to study the 
hybrid origin of descendants from crosses of C. tubulosa 
and C. brevicaudata [47]. 
ITS (internal transcribed spacer) locates between nuclear 
ribosomal RNAs (rRNA) of a precursor transcript, which 
proved valuable for defining relationships among conge-
neric species and closely related genera [41]. ITS sequences 
were PCR-amplified from leaf genomic DNA of eight 
Clematis species of Zhejiang, China [48]. The ITS region 
varied between 534 and 561 bp, with 50 variable sites and 
22 parsimony informative sites. On the ITS-based phyloge-
netic tree, C. patens is closer to C. patens ssp. Tientaiensis 
than to C. finetiana and C. chinensis in one group, while C. 
henryi of subgenus Viorna is closer to C. lasiandra (subge-
nus Viorna) than to C. apiifolia and C. uncinata of subgenus 
Clematis in the other group. ITS2 is a part of ITS, which is 
shorter and easier to amplify. The ITS2 region of Wei Ling 
Xian and its adulterants varied between 220 and 230 bp [49]. 
On the ITS2-based phylogenetic tree, C. chinensis is closer 
to C. hexapetala than to C. mandshurica. These official 
species of Wei Ling Xian form one cluster, while C. 
lasiandra of subgenus Viorna is closer to C. pogonandra 
(subgenus Viorna) than to C. uncinata (subgenus Clematis), 
which does not contradict with ITS results [48]. With ITS2, 
it is also easy to differentiate Wei Ling Xian and plants of 
Sarcandra, Podophyllum, Paeonia and Smilax, which were 
inadvertently or deliberately used as Wei Ling Xian in Chi-
na markets [49]. ITS2 was also used to identify Chuan Mu 
Tong, its adulterants (e.g. Aristolochia and Akebia) and 
closely related species [50]. With ITS2, it is also easy to 
differentiate Chuan Mu Tong and other Clematis species. 
However, ITS2 cannot distinguish C. aethusifolia and C. 
pogonandra (subgenus Viorna), C. leschenaultiana and C. 
siamensis (subgenus Viorna), and C. tangutica and C. ti-
betana (subgenus Clematis). 
Due to low resolving power, the actin I intron is not 
suitable for phylogenetic study of Clematis [51]. The nucle-
ar (nr) ITS and five chloroplast (cp) DNA markers were 
used to deduce the evolutionary relationship of 33 Clematis 
species and related taxa [52]. The traditional subgenus 
Viorna and sect. Atragene (a subgenus in Wang and Li’s 
system of 2005) were monophyletic, whereas taxa of sub-
genus Clematis, as well as those of subgenus Cheiropsis, 
did not form a clade. Substantial morphological divergence 
and meager nucleotide replacements within Clematis imply 
the recent radiation of the genus. Based on 75 species, se-
quences of the nrITS, the cp atpB-rbcL spacer, psbA-trnH- 
trnQ spacer and rpoB-trnC spacer regions were analyzed 
using parsimony, maximum likelihood and Bayesian infer-
ence methods [53]. Analyses of the combined data set by 
the three methods engendered similar trees. Ten major 
clades with various support values were found. The molec-
ular inferences do not support prior morphology-based in-
frageneric classifications but suggest momentous evolu-
tionary convergence in reproductive and vegetative charac-
ters in Clematis. Several branches represent geographically 
distinct groups. C. montana, C. chrysocoma and C. fascicu-
liflora of southwestern China, belonging to subgenus Chei-
ropsis, form clade X and are basal to other clades. C. re-
hderiana, C. leschenaultiana, C. ranunculoides, C. siamen-
sis and C. lasiandra, distributed in southern, eastern and 
southeastern Asia and members of subgenus Viorna, form 
clade VIII and are basal to subgenera Clematis and Atra-
gene. The members of subgenus Clematis, C. delavayi, C. 
peterae, C. heracleifolia, C. pinnata, C. brevicaudata, C. 
taiwaniana and C. apiifolia, are in clade VII, while C. pat-
ens is in clade VI. The raw species of Wei Ling Xian and 
their relatives, C. armandii and its relatives with similar 
drug efficacy are in clade V. Interestingly, C. akebioides, C. 
tangutica, C. tibetana, C. orientalis and C. serratifolia of 
clade I are closer to clade II (subgenus Atragene) than to 
other members of subgenus Clematis. However, relation-
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ships among some closely related species are not resolved, 
e.g., C. tangutica and C. tibetana, C. apiifolia and C. tai-
waniana, C. brachiata and C. strigillosa, and C. uncinata 
and C. meyeniana, suggesting that these taxa may have di-
verged recently. Bayesian dating suggests a fairly ancient 
origin of the genus in the Oligocene (25.99 million years 
ago, mya) and a quite recent species radiation in the Mio-
cene (7.81 mya). Geologic and climatic changes in the late 
Tertiary to Quaternary (2.588 mya-now) might be important 
for the speciation of Clematis, especially in East Asia. 
Long-distance spreading of the fruits by wind, water or an-
imals and significant environmental adaptability might ex-
plain the current world-wide distribution and high species 
diversity. 
Yunnan, China has the most Clematis species in the 
world and Hengduan Mountains of northwestern Yunnan 
are viewed as centers of origin, differentiation and ende-
mism of the genus [42]. ITS and three cp markers, same as 
those of Xie et al. [53], were PCR amplified to study the 
phylogenetic relationship of Clematis [54]. Seventy-three 
species (132 samples) cluster into 18 clades. C. potaninii 
and C. fasciculiflora of subgenus Cheiropsis are basal to 
other taxa. Clade XV containing C. montana, C. gracilifolia, 
C. venusta and C. chrysocoma is close to clade XIV of sub-
genus Clematis. Clade XIII containing C. connata, C. re-
hderiana, C. lasiandra and clades XII and X containing oth-
er members of subgenus Viorna cluster together. Clade VIII 
represents subgenus Atragene and is closer to clade VII 
containing members of Meclatis, subgenus Clematis, which 
matches the results of Xie et al. [53]. C. hexapetala, C. 
terniflora, C. armandii, C. uncinata, C. crassifolia and C. 
patens cluster in clades IV and V. This study also suggests  
a recent species radiation. Most involved species are from 
southwestern China, particularly Hengduan Mountains   
of northwestern Yunnan. The massive diversification of 
modern Clematis occurred in Himalaya-Hengduan region 
during the uplift of the Qinghai-Tibetan Plateau and was 
manipulated by the global geologic and ecologic alterations 
during the late Tertiary [53]. Many plant groups underwent 
adaptive radiation, differentiation and speciation after  
migrating to this region, e.g. Pedicularis [55], Aconitum, 
Corydalis, Primula, Silene, Rhododendron [56], etc. Jiang 
[54] found that relationships among some closely related 
species of Hengduan Mountains are not decided, e.g., C. 
tangutica, C. akebioides and C. tibetana of subgenus Clem-
atis, C. ranunculoides and C. yuanjiangensis of subgenus 
Viorna, suggesting that these taxa might be the result     
of rapid radiation and speciation. C. peterae and C. gouri-
ana of southwestern China, as well as C. lasiandra and   
C. pseudootophora of Subgenus Viorna, might also come 
into being from species radiation. Morphology has diverged 
significantly in these pairs of species, but the molecular 
marker sequences have not yet diverged dramatically. It is 
motivating to study whether the chemical profile has also 
diverged or not, which could be helpful in choosing the 
source plant for the specific medicinal use. Moreover, natu-
ral hybridization may be common in Clematis, since artifi-
cial hybridization among closely related species or even 
among sections is easy and widely used in horticulture 
[23,47]. Many cultivars are obtained by hybridization and 
possess unique pharmaceutical components [13,14]. Due to 
the conflicting position of C. delavayi in the cpDNA and 
ITS trees, Miikeda et al. [52] suggested a hybrid origin of 
this species in the early evolution of the genus. Based on the 
incongruent position in the cpDNA and ITS trees, Jiang [54] 
inferred that C. delavayi, C. peterae, C. parviloba (subge-
nus Clematis), C. connata, C. rehderiana and C. ranuncu-
loides (subgenus Viorna) might have a hybrid origin. ITS 
and psbA-trnH-trnQ can be used as DNA barcodes in the 
authentication of Clematis. 
5  Conclusions 
Clematis is a botanical source for various pharmaceutically 
active components, which has been used in conventional 
Chinese medicine for many centuries. Increasing interest in 
Clematis medicinal resources has led to additional discov-
eries of triterpenoid saponins, flavonoids, coumarins, alka-
loids and many other compounds in various Clematis spe-
cies, and to investigations on their chemotaxonomy, molec-
ular phylogeny and pharmacology. However, around 90% 
of all 355 species have not been explored in phytochemistry, 
molecular biology and pharmacology, which is a gold mine 
of myriad medicinal compounds. Chemotaxonomy tries to 
classify and spot plants by discovering differences and sim-
ilarities in their biochemical compositions, which is of great 
help in pharmaceutical resource discovery. However, the 
results of chemotaxonomy have to be cross-examined with 
those of molecular taxonomy and traditional morphology- 
based classification, in order to streamline the quality con-
trol and guarantee the authenticity of plant materials used in 
the clinical setting, research laboratory and pharmaceutical 
industry. More importantly, chemical and biological re-
search of Clematis medicinal resources should not be re-
stricted in the above aspects, e.g. the biosynthetic pathway 
of secondary metabolites has not been studied; the regula-
tion of Clematis biological processes at genomic level, 
epigenomic level [63], transcriptional and post-transcrip- 
tional levels, and translational and post-translational levels 
is totally unknown, although it is essential for the conserva-
tion, sustainable development and utilization of the Clema-
tis medicinal resources. The biological and chemical studies 
of Taxus [57] and Polygonum [58] with the use of omics 
technologies provide a paradigm of the active integration of 
various state-of-the-art methodologies into the early stage of 
the drug research and development. Systems biology and 
omics techniques will play an increasingly significant role 
in future medical research involving bioactive compounds 
of Clematis. 
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